NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
The U.S. Army Medical Research Institute of Infectious Diseases in Frederick, Maryland, is designed to handle pathogens that cause serious or potentially lethal diseases, which require the research performed on them be contained to specialized laboratories. In 2007 a decision was made to expand those facilities causing concern among area residents that public health and safety risks, and strategies to mitigate those concerns were not adequately considered in the decision to go forward with the expansion. In Evaluation of the Health and Safety Risks of the New USAMRIID High Containment Facilities at Fort Detrick, Maryland a group of experts in areas including biosafety, infectious diseases, industrial hygiene, environmental engineering, risk assessment and epidemiology, explored whether measures were being taken to ensure prevention and mitigation of risk to the health and safety of workers and the public. They also assessed whether the procedures and regulations employed meet accepted standards of the Centers for Disease Control and Prevention and the National Institutes of Health.
Evaluation of the Health and Safety Risks of the New USAMRIID High Containment Facilities at Fort Detrick, Maryland evaluates the health and safety aspects of the environmental impact statement developed to support the construction of the new laboratories and explores the institute's operating requirements, medical and emergency management response plans and communication and cooperation with the public. The book recommends that USAMRIID continue to set high standards for advancing security, operational, and biosurety measures, and that additional measures be taken to provide assurance that experienced medical professionals are readily available to consult on unusual infectious diseases. It also suggests that USAMRIID expand its two-way communications with the public.
Contents
- THE NATIONAL ACADEMIES
- COMMITTEE TO REVIEW THE HEALTH AND SAFETYRISKS OF HIGH-BIOCONTAINMENT LABORATORIES AT FORT DETRICK
- BOARD ON LIFE SCIENCES
- Preface
- Abbreviations
- Summary
- 1. Introduction
- 2. Comparative Evaluation of Procedures and Regulations for Biocontainment Facilities
- 3. Medical and Emergency Management Response
- 4. Review of the USAMRIID Environmental Impact Statement
- 5. Communications and Cooperation with the Public
- References
- Appendix Biographical Information on the Committee to Review the Health and Safety Risks of High-Biocontainment Laboratories at Fort Detrick
This project was supported by Contract No. W81K04-06-D-0023 between the National Academy of Sciences and the U.S. Department of Defense. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.
- NLM CatalogRelated NLM Catalog Entries
- Review Assistance to the U.S. Army Medical Research and Materiel Command with Preparation of a Risk Assessment for the Medical Countermeasures Test and Evaluation (MCMT&E) Facility at Fort Detrick, Maryland: A Letter Report[ 2011]Review Assistance to the U.S. Army Medical Research and Materiel Command with Preparation of a Risk Assessment for the Medical Countermeasures Test and Evaluation (MCMT&E) Facility at Fort Detrick, Maryland: A Letter ReportNational Research Council (US) Committee on Risk Assessment for the Medical Countermeasures Test and Evaluation (MCMT&E) Facility at Fort Detrick, Maryland. 2011
- Procedures and methods of benefit assessments for medicines in Germany.[Eur J Health Econ. 2008]Procedures and methods of benefit assessments for medicines in Germany.Bekkering GE, Kleijnen J. Eur J Health Econ. 2008 Nov; 9 Suppl 1:5-29.
- [Procedures and methods of benefit assessments for medicines in Germany].[Dtsch Med Wochenschr. 2008][Procedures and methods of benefit assessments for medicines in Germany].Bekkering GE, Kleijnen J. Dtsch Med Wochenschr. 2008 Dec; 133 Suppl 7:S225-46. Epub 2008 Nov 25.
- American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.[J Clin Oncol. 2003]American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.American Society of Clinical Oncology. J Clin Oncol. 2003 Jun 15; 21(12):2397-406. Epub 2003 Apr 11.
- Review Risk management frameworks for human health and environmental risks.[J Toxicol Environ Health B Cri...]Review Risk management frameworks for human health and environmental risks.Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S. J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec; 6(6):569-720.
- Evaluation of the Health and Safety Risks of the New USAMRIID High-Containment F...Evaluation of the Health and Safety Risks of the New USAMRIID High-Containment Facilities at Fort Detrick, Maryland
Your browsing activity is empty.
Activity recording is turned off.
See more...